Free Trial

Biomea Fusion (BMEA) Short Interest Ratio & Short Volume

Biomea Fusion logo
$4.32 +0.07 (+1.65%)
Closing price 04:00 PM Eastern
Extended Trading
$4.33 +0.01 (+0.25%)
As of 06:52 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

Biomea Fusion Short Interest Data

Biomea Fusion (BMEA) has a short interest of 11.54 million shares, representing 36.48% of the float (the number of shares available for trading by the public). This marks a 6.16% increase in short interest from the previous month. The short interest ratio (days to cover) is 12.9, indicating that it would take 12.9 days of the average trading volume of 865,602 shares to cover all short positions.

Current Short Interest
11,540,000 shares
Previous Short Interest
10,870,000 shares
Change Vs. Previous Month
+6.16%
Dollar Volume Sold Short
$44.78 million
Short Interest Ratio
12.9 Days to Cover
Last Record Date
December 31, 2024
Outstanding Shares
36,240,000 shares
Float Size
31,630,000 shares
Short Percent of Float
36.48%
Today's Trading Volume
501,531 shares
Average Trading Volume
865,602 shares
Today's Volume Vs. Average
58%
Short Selling Biomea Fusion?
cover of A Guide to High-Short-Interest Stocks and How to Trade Them ebook

Sign up to receive the latest short interest report for Biomea Fusion and its competitors with MarketBeat's FREE newsletter.

Skip Charts & View Short Interest History

BMEA Short Interest Over Time

BMEA Days to Cover Over Time

BMEA Percentage of Float Shorted Over Time

Biomea Fusion Short Interest History

Report DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date
12/31/202411,540,000 shares $44.78 million +6.2%36.5%12.9 $3.88
12/15/202410,870,000 shares $61.31 million +9.6%34.4%11.4 $5.64
11/30/20249,920,000 shares $71.82 million +5.4%31.4%12.8 $7.24
11/15/20249,410,000 shares $61.45 million +11.0%29.7%12.1 $6.53
10/31/20248,480,000 shares $79.46 million +3.5%30.2%11 $9.37
10/15/20248,190,000 shares $89.84 million +3.3%29.2%10.1 $10.97
9/30/20247,930,000 shares $80.09 million +4.5%28.3%10.1 $10.10
9/15/20247,590,000 shares $59.58 million -1.4%27.0%10.7 $7.85
8/31/20247,700,000 shares $56.44 million +7.8%27.5%6.9 $7.33
8/15/20247,140,000 shares $41.55 million -8.0%25.5%5.3 $5.82
7/31/20247,760,000 shares $43.22 million -1.8%27.7%5.8 $5.57
7/15/20247,900,000 shares $42.34 million +0.8%28.4%6.3 $5.36
6/30/20247,840,000 shares $35.28 million -33.5%28.2%5.9 $4.50
6/15/202411,790,000 shares $66.50 million -1.2%42.4%8.5 $5.64
5/31/202411,930,000 shares $125.50 million -9.2%42.9%9.8 $10.52
5/15/202413,140,000 shares $173.97 million -5.9%47.2%13.3 $13.24
4/30/202413,970,000 shares $150.04 million +1.1%50.3%14 $10.74
4/15/202413,820,000 shares $172.89 million +4.4%49.9%13.3 $12.51
3/31/202413,240,000 shares $197.94 million +18.2%47.8%13 $14.95
3/15/202411,200,000 shares $199.92 million +6.9%40.6%11.5 $17.85
2/29/202410,480,000 shares $183.40 million -11.0%38.0%8.4 $17.50
2/15/202411,780,000 shares $204.38 million +19.0%42.7%8.6 $17.35
1/31/20249,900,000 shares $178.99 million -3.5%33.5%7.5 $18.08
1/15/202410,260,000 shares $156.05 million +4.0%34.7%8.3 $15.21
12/31/20239,870,000 shares $143.31 million -9.8%33.4%8.3 $14.52
12/15/202310,940,000 shares $155.02 million +23.5%37.0%9.7 $14.17
11/30/20238,860,000 shares $133.52 million +1.7%30.0%9.1 $15.07
11/15/20238,710,000 shares $81.09 million +7.4%29.5%19.5 $9.31
10/31/20238,110,000 shares $82.88 million +3.3%27.5%18.6 $10.22
10/15/20237,850,000 shares $83.52 million -6.6%26.6%17.7 $10.64
9/30/20238,400,000 shares $115.58 million -0.9%28.5%17.7 $13.76
9/15/20238,480,000 shares $128.56 million +4.7%28.8%13.5 $15.16
8/31/20238,100,000 shares $136.65 million +4.7%27.5%10.5 $16.87
8/15/20237,740,000 shares $147.45 million +3.3%26.2%9.4 $19.05
7/31/20237,490,000 shares $166.65 million -9.5%25.4%9 $22.25
7/15/20238,280,000 shares $190.61 million -0.1%28.1%9.8 $23.02
6/30/20238,290,000 shares $181.97 million +28.5%28.2%9.3 $21.95
6/15/20236,450,000 shares $237.49 million +4.4%21.9%5 $36.82
5/31/20236,180,000 shares $209.87 million +0.3%21.0%6 $33.96
5/15/20236,160,000 shares $209.19 million +1.3%19.7%6.8 $33.96
Stunning Trump Manhattan Project Now Underway (Ad)

Just as I predicted, President Trump announced his #1 move during his first 100 days... His allies are calling it Trump’s Manhattan Project.

4/30/20236,080,000 shares $179.18 million +28.5%20.6%7 $29.47
4/15/20234,730,000 shares $113.43 million +114.0%16.2%6 $23.98
3/31/20232,210,000 shares $68.53 million +279.2%7.6%3.2 $31.01
3/15/2023582,800 shares $9.02 million +49.3%2.4%5.8 $15.48
2/28/2023390,300 shares $5.01 million -34.3%1.6%5.2 $12.84
2/15/2023594,000 shares $6.29 million -1.8%2.4%8.9 $10.59
1/31/2023604,700 shares $5.76 million +14.6%2.5%8.9 $9.52
1/15/2023527,900 shares $3.93 million -3.7%2.1%7.5 $7.44
12/30/2022548,400 shares $4.62 million +5.5%2.2%7.9 $8.43
12/15/2022520,000 shares $3.88 million +1.4%2.1%6.9 $7.47
11/30/2022512,700 shares $3.69 million -9.1%2.1%6.2 $7.19
11/15/2022564,100 shares $4.55 million -7.1%2.3%6.3 $8.06
10/31/2022606,900 shares $6.68 million -8.8%2.6%5.4 $11.00
10/15/2022665,500 shares $6.02 million +18.8%2.9%5.8 $9.05
9/30/2022560,300 shares $5.48 million +35.6%2.4%4.2 $9.78
9/15/2022413,200 shares $5.14 million +1.7%1.8%2.2 $12.44
8/31/2022406,400 shares $4.67 million +15.1%1.8%2 $11.50
8/15/2022353,000 shares $4.33 million -21.8%1.5%1.7 $12.27
7/31/2022451,600 shares $4.79 million -17.2%2.0%2 $10.60
7/15/2022545,300 shares $6.58 million -78.2%2.4%2.3 $12.06
6/30/20222,500,000 shares $29.95 million -12.6%10.8%11 $11.98
6/15/20222,860,000 shares $25.08 million +22.2%12.4%13.6 $8.77
5/31/20222,340,000 shares $12.85 million +2.2%12.6%15.5 $5.49
5/15/20222,290,000 shares $8.84 million +4.6%12.3%15.8 $3.86
4/30/20222,190,000 shares $6.57 million +9.5%12.1%21.1 $3.00
4/15/20222,000,000 shares $9.10 million +7.0%11.0%17.6 $4.55
3/31/20221,870,000 shares $8.34 million +5.1%10.3%14.5 $4.46
3/15/20221,780,000 shares $10.40 million +0.6%9.8%12.5 $5.84
2/28/20221,770,000 shares $11.35 million +2.9%9.8%10.3 $6.41
2/15/20221,720,000 shares $10.85 million +22.0%9.5%9.9 $6.31
1/31/20221,410,000 shares $10.10 million +28.2%8.0%7.4 $7.16
1/15/20221,100,000 shares $9.93 million -32.5%6.7%5.7 $9.03
12/31/20211,630,000 shares $12.14 million +4.5%9.9%9.5 $7.45
12/15/20211,560,000 shares $12.93 million +3.3%9.5%10.1 $8.29
11/30/20211,510,000 shares $18.23 million -35.7%9.4%12.2 $12.07
11/15/20212,350,000 shares $27.45 million +13.0%14.6%20.4 $11.68
10/29/20212,080,000 shares $22.34 million +5.6%12.9%20.4 $10.74
10/15/20211,970,000 shares $22.91 million +20.1%12.1%21.8 $11.63
9/30/20211,640,000 shares $19.63 million +13.9%10.1%17.9 $11.97
9/15/20211,440,000 shares $15.31 million +5.1%8.8%13.3 $10.63
8/31/20211,370,000 shares $19.11 million +30.5%8.5%12.3 $13.95
8/13/20211,050,000 shares $11.14 million No Change6.4%9.3 $10.61

BMEA Short Interest - Frequently Asked Questions

What is Biomea Fusion's current short interest?

Short interest is the volume of Biomea Fusion shares that have been sold short but have not yet been closed out or covered. As of December 31st, investors have sold 11,540,000 shares of BMEA short. 36.48% of Biomea Fusion's shares are currently sold short. Learn More on Biomea Fusion's current short interest.

What is a good short interest ratio for Biomea Fusion?

The short interest ratio, also known as the "days to cover ratio", is calculated by dividing the number of shares of a stock sold short divided by its average trading volume. A short interest ratio ranging between 1 and 4 generally indicates strong positive sentiment about a stock and a lack of short sellers. A short interest ratio of 10 or greater indicates strong pessimism about a stock. BMEA shares currently have a short interest ratio of 13.0. Learn More on Biomea Fusion's short interest ratio.

Which institutional investors are shorting Biomea Fusion?

As of the most recent reporting period, the following institutional investors, funds, and major shareholders have reported short positions of Biomea Fusion: Wolverine Trading LLC, Ikarian Capital LLC, and Walleye Trading LLC. These positions are disclosed in Form 13F filings with the Securities and Exchange Commission.

What is a good short interest percentage for Biomea Fusion?

Companies that have a short interest as a percentage of float below 10% indicates positive investor sentiment and few short sellers. Stocks with a short interest percentage above 10% is considered high, suggesting some investors are pessimistic about the stock. Companies with a short interest percentage of 20% or more indicates widespread negative sentiment. 36.48% of Biomea Fusion's floating shares are currently sold short.

Is Biomea Fusion's short interest increasing or decreasing?

Biomea Fusion saw a increase in short interest during the month of December. As of December 31st, there was short interest totaling 11,540,000 shares, an increase of 6.2% from the previous total of 10,870,000 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment.

What is Biomea Fusion's float size?

Biomea Fusion currently has issued a total of 36,240,000 shares. Some of Biomea Fusion's outstanding shares are available for trading, while others are subject to various restrictions. The public float, also referred to as floating shares or "the float", are shares that publicly owned, unrestricted and available to trade on the open market. Biomea Fusion currently has a public float of 31,630,000 shares.

How does Biomea Fusion's short interest compare to its competitors?

36.48% of Biomea Fusion's shares are currently sold short. Here is how the short interest of companies in the industry of "pharmaceutical products" compare to Biomea Fusion: CARGO Therapeutics, Inc. (18.87%), Kura Oncology, Inc. (16.00%), Humacyte, Inc. (28.38%), Opthea Limited (0.05%), Mind Medicine (MindMed) Inc. (36.65%), Erasca, Inc. (20.06%), Verve Therapeutics, Inc. (22.52%), Stoke Therapeutics, Inc. (14.12%), Cartesian Therapeutics, Inc. (23.73%), MeiraGTx Holdings plc (2.37%),

Which stocks are the most shorted right now?

As of the most recent reporting period, the following stocks had the largest short interest positions: AppLovin Co. ($5.83 billion), Charter Communications, Inc. ($3.77 billion), Reddit, Inc. ($2.98 billion), The Kroger Co. ($2.97 billion), International Paper ($2.64 billion), SoFi Technologies, Inc. ($1.99 billion), Rivian Automotive, Inc. ($1.93 billion), Onsemi ($1.81 billion), SoundHound AI, Inc. ($1.59 billion), and Moderna, Inc. ($1.57 billion). View all of the most shorted stocks.

What does it mean to sell short Biomea Fusion stock?

Short selling BMEA is an investing strategy that aims to generate trading profit from Biomea Fusion as its price is falling. BMEA shares are trading up $0.04 today. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit.

How does a short squeeze work against Biomea Fusion?

A short squeeze for Biomea Fusion occurs when it has a large amount of short interest and its stock appreciates in price. This forces short sellers to cover their short interest positions by buying actual shares of BMEA, which in turn drives the price of the stock up even further.

How often is Biomea Fusion's short interest reported?

Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including BMEA, twice per month. The most recent reporting period available is December, 31 2024.




This page (NASDAQ:BMEA) was last updated on 1/22/2025 by MarketBeat.com Staff
From Our Partners